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During normal hematopoietic differentiation, lineage-specific cell surface an- 
tigens have been identified in both avian (1) and mammalian (2) species. These 
differentiation antigens  can  be  found  in  most  cellular  compartments  of the 
hematopoietic system and have added a new dimension to the classical morpho- 
logic identification of individual  cell  types during normal differentiation and 
leukemia. In addition, expression of these antigens at the cell surface has made 
it possible to purify live cells in a functionally intact state. 
In the mouse, the most extensively studied antigen systems have been those of 
the various functionally distinct lymphocyte subpopulations  (e.g.,  LyT (3) and 
LyB (4)). In addition, the expression of a number of endogenous retroviruses or 
products thereof have been observed in the mouse within lymphoid organs (5, 
6),  reproductive organs (7),  and  in  the embryo (8),  and have been likened to 
differentiation antigens  because  of their apparent  lineage-specific expression. 
These retroviral antigens are apparently encoded by multiple retroviral  gene 
sequences integrated throughout normal mouse genomic DNA  (9).  However, 
many more sequences than antigenic gene products have been identified, and 
little is known of the possible function of these endogenous viral sequences. 
A panel of monoclonal antibodies has been developed in our laboratory which 
has  allowed  the  serologic  identification  and  distinction  of a  wide  variety  of 
murine ecotropic, xenotropic, and dualtropic viruses (10-12). The high degree 
of specificity of these reagents has made possible the distinction of qualitatively 
different endogenous retroviral  products  expressed  in  tissues  of normal  and 
leukemic mice, something that  has  not been possible  with recombinant  DNA 
technology. 
In  the current study, we have identified a  unique retroviral envelope gp70 
protein, the expression of which is linked to normal erythroid differentiation in 
both the fetus and adult mouse. This viral protein is expressed at the cell surface 
and  appears  to  be  serologically and  structurally similar  to  a  gp70  previously 
found to be expressed during the late malignant, but not the early proliferative 
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phase of Friend  erythroleukemia  (13).  The presence of this gp70  may identify 
the  target  cell  of malignant  transformation  induced  by the  Friend  virus (FV) 1 
complex. 
Materials and  Methods 
Animals.  C57BL/10Sn,  B10.A,  A.BY, and A]WySn mice were purchased from The 
Jackson  Laboratory, Bar  Harbor,  ME.  F~  hybrids  were  bred at the  Rocky  Mountain 
Laboratories, Hamilton, MT. Adult mice were between 2 and 4 months of age. 
Cells and Viruses.  The B-tropic strain of FV complex was obtained from Dr. F.  Lilly, 
Albert  Einstein,  School  of  Medicine,  Bronx,  NY.  The  virus  stocks  used  for  animal 
inoculation were prepared in (C57BL/10Sn  X  A.BY)F~ mice and assayed as previously 
reported  (14).  SC-1  cells  (15)  were  maintained  and  infected  with  virus as  previously 
described (16).  The mink lung fibroblast cell line CCL64 was obtained from Dr. M. W. 
Cloyd, Rocky Mountain Laboratories and maintained in RPMI 1640 media supplemented 
with 2% fetal calf serum (FCS).  The Friend-mink cell focus-inducing virus (FMCF-1) and 
Friend-murine  leukemia virus (F-MuLV)  strain  57  were obtained from Dr.  L.  Evans, 
Rocky Mountain Laboratories. Xenotropic-MuLV including AKR-6 were obtained from 
Dr. M. W. Cloyd, Rocky Mountain Laboratories. 
The clonal cell lines AA60, AA62, and L2 were obtained from spleen cells of grossly 
leukemic (B 10.A X A/WySn)FI mice 60 d after FV inoculation. The cell lines were cloned 
by limiting dilution  immediately after in  vitro growth  was detected.  The cells caused 
transplantable  tumors  in  syngeneic mice.  These  lines  released  no infectious virus nor 
could reverse transcriptase be detected in the supernatants. Growth in  1% dimethylsulf- 
oxide caused all of the cell lines to synthesize hemoglobin (17). 
The other cell lines used in this study have been described previously. They include 
AA41, YA97, and 2C (18);  AA25 (19);  7303,  7229,  7201,  7320,  and 2800  (20); P815 
(21);  M BL-2 (22).  P3-NS 1/1-Ag4-1 was obtained from the Salk Cell Distribution Center, 
La Jolla, CA (23). 
Early and Late Leukemic Spleen Cells and Embryonic  Liver Cells.  Leukemic spleen cells 
were obtained from (B10.A X  A/WySn)F1  mice given 5,000  focus-forming units (FFU) 
of  FV  intravenously.  Large  (>1  g)  leukemic  spleens  were  removed  and  single  cell 
suspensions were prepared in phosphate-buffered balanced salt solution (PBBS)  8-10 d 
after virus inoculation (early leukemic spleen cells)  and 30-60 d  after virus inoculation 
(late leukemic spleen cells) (13). Fetal liver cells were prepared from (B 10.A X A]WySn)F1 
12-18 d  fetuses. Gestational ages were determined in the following manner.  Each cage 
was partitioned with a removable wire screen that separated one male from two females. 
After 3 d, the screens were removed and 24 h later the males were removed. This 24-h 
period was considered day 0. Pregnancy generally occurred in less than half of the females. 
Livers from the fetuses of an individual  female were pooled and single cell suspensions 
prepared. 
Stimulation  of Erythropoiesis.  An  erythroproliferative  state  was  induced  in  vivo  by 
injection of mice with a hemolytic agent, phenylhydrazine (PHZ) (24). PHZ was dissolved 
in PBBS at 1 mg]ml. This solution was inoculated immediately intraperitoneally at a dose 
of 1 ml (1 mg) per day for 3 d. Mice were sacrificed on day 4. At this time, the hematocrit 
was generally <30% and the spleens were slightly enlarged. 
Antisera and Monoclonal  Antibodies.  Monoclonal antibodies 18-1,  24-6,  18-2,  618, and 
18-6 were derived from mice undergoing graft-vs.-host disease. A detailed description of 
these antibodies and their viral specificities has been reported (11,  12).  All are reactive 
with endogenous MuLV. Monoclonal antibodies 48, 273 (10), and 514 (25) were derived 
from mice inoculated with FV and F-MuLV, respectively. All of the monoclonals except 
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18-2 have specificity for gp70 or the gp70-p 15(E) disulfide-linked complex gp85 (10-12, 
25). The polypeptide specificity of 18-2 is unknown. 
The anti-spectrin antiserum was prepared in rabbits by injection of spectrin purified 
from mouse erythrocyte ghosts (26).  The specificity of this reagent has been confirmed 
both by radioimmunoassay, immunoprecipitation, and immunofluorescence on acetone- 
fixed cells (data not shown). Using a panel of erythroid, myeloid, and lymphoid cell lines 
(20), this serum was found to bind only to those cells of the erythroid lineage. 
Immunofluorescence Assays.  Indirect membrane immunofluorescence on live cells was 
carried out in two ways. The standard technique utilizing monocional antibody and FITC- 
conjugated goat anti-mouse Ig has been described previously (13). This assay was used on 
late Friend erythroleukemic spleen cells, leukemia cell lines, thymus, and fetal liver cells 
because of the relative paucity of membrane Ig-positive B lymphocytes. Examination of 
adult spleen and bone marrow cells, however, required the use ofarsenylated monoclonal 
antibodies prepared by the technique of Wallace and Wofsy (27) and detected by FITC- 
rabbit anti-ars prepared in our laboratory. 
Staining for spectrin was carried out on acetone-fixed cells deposited on microscope 
slides by cytocentrifugation. Binding of the rabbit anti-spectrin antibodies was detected 
by fluorescein isothiocyanate guinea pig anti-rabbit IgG prepared in our laboratory. 
Histochemistry.  The a-naphyl-butyrate esterase (a-NBE) and Sudan black stains used in 
this study have been described previously (20).  Cells  to be stained  were prepared by 
cytocentrifugation, air dried, fixed 4 min in formaldehyde vapor, and stored at -70°C. 
Radiolabeling  of Cells.  This procedure has  been  published  previously (13).  Briefly, 
leukemic spleen cells,  leukemia cell lines,  and embryonic liver cells were washed three 
times with PBBS and resuspended in Dulbecco's phosphate-buffered saline (DPBS) at 20 
×  10  ~ cells/ml. 1 ml of this solution was added to a glass vial containing 50 ttg of Iodogen 
(Pierce Chemical Co., Rockford, IL). 1 mCi of carrier-free 1~I (ICN, Riverside, CA) was 
added and the solution was  incubated on ice for  10 min.  The cells were washed with 
DPBS and lysed in 0.5% Nonidet P-40, 0.15 M sodium chloride, and 0.01  N Tris-HCl, 
pH 7.38. The lysates were stored at -70°C. 
Immunoprecipitation  and Sodium  Dodecyl Sulfate-Polyacrylamide  Gel Electrophoresis (SDS- 
PAGE).  The methods of immunoprecipitation using formalin-fixed Staphylococcus aureus 
Cowan I strain and analysis of immunoprecipitates by SDS-PAGE using autoradiography 
have been described previously (13).  For reasons of low affinity, immunoprecipitation of 
F-MuLV gp70 required a mixture of antibodies 48 and 273, each of which reacts with a 
different epitope of the gp70 molecule (10). 
Two-dimensional Peptide Mapping.  Cell surface radiolabeled antigens were immunopre- 
cipitated and analyzed by SDS-PAGE. The appropriate gp70 was visualized by autora- 
diography and excised from the gel. The gel slice was rehydrated with distilled water, 
minced with a scalpel, and ground in a Dounce-homogenizer. The finely dispersed gel 
was incubated in 0.05 M NH4HCOs, 0.1% SDS,  1% 2-mercaptoethanol, pH 8.1 buffer at 
37°C for 4  h.  The gel matrix was removed by centrifugation at  10,000 g for 30 min. 
Trichloroacetic acid was added to the supernatant to a final concentration of 20%. After 
incubation on ice for 1 h, the denatured protein was collected by centrifugation at 10,000 
g for 45 rain. The pellet was washed once with 70:30 ethanol/ether and then with ether. 
After evaporation of the ether, the protein was dissolved in 200 ttl of 0.05 M NH4HCOs, 
pH  8.1.  To this  solution  12  ttg  of a-chymotrypsin (Worthington  Biochemical  Corp., 
Freehold, NJ) was added and the solution was incubated for 2 h. An additional 10/zg of 
a-chymotrypsin was added and the solution was incubated for 2 h.  Distilled water was 
added and  the sample  was  lyophilized. This was  repeated  three  times to  remove the 
NH4HCOs. The pellet was then resuspended in 5 #1 of distilled water and applied to a 
thin layer plate (Polygram Cei 300; Brinkman Instruments, Westbury, NY). The sample 
was electrophoresed at 600 V for 45 rain at 4°C in a buffer containing 0.05% acetic acid 
and 0.005% pyridine in water. Following drying, the thin layer plate was then chromato- 
graphed using a 43:57 pyridine, n-butanol solvent system. Following drying the sample 
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Results 
Monoclonat  Antibodies  Spec~c for Endogenous Murine Retroviruses  React With the 
Celt  Surface  of FV-induced  Erythroleukemia  Cells.  A  panel  of envelope-specific 
monoclonal antibodies reactive with various endogenous and exogenous retro- 
viruses was used to characterize the non-F-MuLV gp70 expressed on the surface 
of FV-induced late leukemic spleen cells. Three antibodies,  18-1, 24-6, and  18- 
6, were found to react with approximately 50-60% of late leukemic spleen cells 
and with an FV-induced erythroleukemia cell line AA60 (Table I). In a previous 
report,  we showed that  antibody  18-1  reacts  with  all  endogenous retroviruses 
tested, whereas antibody 24-6  detects an antigen  common to most xenotropic 
viruses (11). In contrast to 24-6, which reacts with xenotropic viruses as a group 
and with a large number of MCF viruses, antibody 18-6 has been found to react 
with  only  one  xenotropic  (AKR-6)  and  only  four  out  of several  dozen  MCF 
viruses studied (11). Neither AA60 nor the late leukemic spleen cells from which 
it  was  derived  reacted  with  antibodies  specific  for  F-MuLV  and  endogenous 
ecotropic viruses (48,273,  18-2) (Table I). 
Since antibody 18-6 also reacts with some MCF viruses (Table I), we used two 
monoclonal antibodies (618,  514) to further characterize this erythroleukemia- 
associated antigen.  In our examination of 50-60 different MCF viral isolates of 
diverse origin,  all have been reactive with one or both of these two antibodies. 
Since these antibodies do not react with ecotropic, xenotropic, or amphotropic 
virus, they are considered MCF specific (12, 25).  Neither 618 nor 514 reacted 
with late  FV spleen cells (Table I), suggesting that  the  24-6+,  18-6+,  48/273- 
gp70  expressed  by these  cells resembled a  xenotropic,  not an  MCF envelope 
protein.  In  contrast,  a  subpopulation  of  the  cell  line  AA60  expressed  a 
TABLE  I 
Reactivity of Anti-MuL V Envelope Antibodies With FV-Induced Erythroleukemia Cells 
Monoclonal  Viral specificity*  Late FV 
AA60 cell line 
antibody  Friend*  Akv  Xeno  MCF  spleen 
18-1  -  +  +  +  559  100 
48  +  -  -  -  <5  0 
273  +  -  -  -  <5  0 
18-2  +  +  -  +  <5  0 
24-6  -  -  +!  +'  60  100 
18-6  _  _  +!  +1  58  100 
618  -  -  -  +  <5  10-20 
514  -  -  -  +  <5  10-20 
* This information represents a  summary of cumulative data reported previously in detail (10-12, 
25). 
* Friend, Friend ecotropic virus (F-MuLV); Akv, endognous ecotropic virus; Xeno, xenotropic virus; 
MCF, MCF virus. 
0 Numbers represent the percent of total viable cells staining by indirect membrane immunofluores- 
cence with the respective monoclonal antibodies. 
! As described in the text, 24-6 reacts with a group-specific determinant expressed by most xenotropic 
viruses, whereas 18-6 reacts with only one minor subgroup of xenotropic viruses. 
'  Antibody 24-6  reacts with a  majority of MCF viruses, whereas 18-6  reacts with only 3-5  out of 
>50 MCF viruses tested to date. BRITT  ET  AL  1595 
618/514+  gp70,  suggesting that an  MCF-like gp70  was expressed in this cell 
population  but  was  apparently  distinct  from  the  18-6+  gp70  because  of the 
disparity in frequency of positive cells. 
Expression of an 18-6 Reactive Antigen on Erythroid Cell Lines.  Table II presents 
the results of a  survey of various hematopoietic cell lines examined by indirect 
membrane immunofluorescence for the binding of antibody 18-6. It can be seen 
that 18-6 reacted with seven out of eight of the erythroid lines but with none of 
the myeloid, mast cell, or lymphoid lines, suggesting the possibility that 18-6 may 
define an erythroid-specific determinant. 
Cells of the Normal Hematopoietic System Express a Cell Surface Antigen  Recognized 
by  Antibody  18-6.  If antibody  18-6  reacted  with  a  determinant  specific  for 
erythroid cell lines, it might be expected that this antigen should be expressed 
by cells during normal erythroid differentiation. We therefore examined adult 
spleen and bone marrow cells with  18-6-ars and FITC-rabbit anti-ars (see Mate- 
rials and Methods). As shown in Table IIIA, both of these hematopoietic organs 
contained a minor, but clearly recognizable, subpopulation of 18-6 reactive cells. 
In contrast to the findings in adult animals, the liver of early fetuses contained 
a high frequency of 18-6 reactive cells (Table IIIA). As the liver is the primary 
site of erythropoiesis in the fetus (28),  this result suggested that antibody  18-6 
was indeed detecting an antigen expressed on cells of the erythroid lineage. In 
TABLE  II 
Reactivity of Antibody  18-6 With Ceil Lines of Differing Lineage 
% 18-6 positive 
Cell line  Lineage  cells* 
AA60  Erythroid  *  100 
AA62  Erythroid  100 
AA25  Erythroid  ! 00 
AA41  Erythroid  100 
YA97  Erythroid  100 
2C  Erythroid  100 
L2  Erythroid  10-20 
2800  Erythroid  0 
7229  Myeloidg  0 
7235  Myeloid  0 
7301  Myeloid  0 
7320  Myeloid  0 
P815  Mast cell  !  0 
7303  Lymphoid  ~  0 
MBL-2  Lymphoid  0 
NS-1  Lymphoid  0 
* Reactivity was determined by indirect membrane immunofluorescence. 
* The erythroid cell type was determined by the capacity to be induced 
to  hemoglobin production by  dimethyl sulfoxide,  the  expression  of 
spectrin, and/or positive staining for a-naphyl butyrate esterase. 
J The myeloid cell type was determined by morphology in the case of well 
differentiated cells and by positive staining with Sudan black. 
! P815  is reported  to  be of mast cell  origin and contains cytoplasmic 
granules that stain with neutral red. 
The lymphoid cell type was determined by morphology, the expression 
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TABLE III 
Frequency of 18-6 Reactive Cells in Hematopoietic Organs 
Organ  18-6"  Mlg+*  Erythroid*  MyeloidJ 
A. Adult spleen  3  39  3  8 
Adult bone marrow  3  8  22  55 
Adult thymus  <1  <1  <1  <1 
Early fetal liver  !  58  <1  70  17 
B. Spleen post-PHZ  23  4  61  16 
Bone marrow post-PHZ  25  2  63  32 
Thymus post-PHZ  <1  <1  NT  NT 
* The frequency of membrane Ig (MIg) positive cells (B lymphocytes)  was determined 
by direct immunofluorescence  with FITC-goat anti-mouse Ig. Cells expressing the 
18-6 reactive antigen were detected by indirect membrane immunofluorescence  as 
described in Materials  and Methods. 
* Erythroid cells  were identified by histochemical  staining  for a-naphyl butyrate esterase 
and staining with anti-spectrin antiserum. 
0 Myeloid  cells were identified by morphology in Giemsa-stained  preparations and by 
demonstration of characteristic Sudan black staining cytoplasmic  granules. 
! Fetal liver cells were obtained (without attention to stage of gestation) at the earliest 
visible sign of pregnancy. 
NT, not tested. 
addition,  this  high  frequency of 18-6  positive  cells  corresponded  to  the  high 
frequency of cells  expressing  two  erythroid  markers  in  the  mouse,  a-naphyl- 
butyrate esterase (a-NBE) and spectrin (Table IIIA). 
Further evidence of the erythroid nature of cells detected by antibody  18-6 
was obtained  by determining the frequency of 18-6  positive cells during fetal 
development.  At various times after impregnation, fetuses were  removed and 
the frequency of cells from the fetal liver reacting with 18-6 was quantified. The 
frequency of positive cells decreased from ~70% on day 12 of gestation to <5% 
immediately before  birth,  coincident with  a  similar  decrease  in  frequency of 
spectrin-positive cells (Fig.  1).  These results also correlated with the previously 
reported  progressive  decline  of morphologically  recognizable  erythroid  cells 
within the fetal liver during embryogenesis (28). 
Pertubation  of Normal Erythropoiesis in Adults Caused an Increased Frequency of 18- 
6 Reactive Cells.  The low frequency of 18-6 reactive cells in normal adult bone 
marrow  and  spleen  as  compared  to  their  high  incidence  in  early  fetal  liver 
suggested  that  during  homeostatic  conditions only a  minor  subpopulation  of 
erythroid cells at a specific stage of differentiation expressed the antigen detected 
by antibody  18-6.  Pertubation  of normal hematopoiesis might then lead to an 
expansion of the population of 18-6 reactive cells. Erythropoiesis was stimulated 
by phenylhydrazine (PHZ),  an agent that causes a  profound hemolytic anemia 
and increased erythropoiesis. After PHZ treatment (see Materials and Methods), 
the  frequency of 18-6  positive  cells  increased  seven-  to  eightfold in  both  the 
spleen and bone marrow (Table IIIB). In the same cell populations the frequency 
of ~-NBE staining cells increased ~30-fold in the spleen as compared to a  3- to 
4-fold increase in the bone marrow (Table IIIB). The frequency of cells exhib- 
iting morphological and histochemical characteristics (Sudan black staining) of BRITT  ET  AL.  1597 
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FIGURE  1.  Frequency of antibody  18-6  reactive cells in liver. Liver cells from gestationally 
timed fetuses were assayed by  indirect membrane immunofluorescence with antibody  18-6 
and FITC-goat anti-mouse [g,  Bars represent the percent of cells expressing the 18-6 reactive 
determinant at the ceil surface. •  represents the frequency of spectrin-positive cells assayed 
after fixation with acetone. 
myeloid cells decreased slightly in the bone marrow and increased slightly in the 
spleen (Table IIIB). The decrease in frequency of membrane Ig positive lymph- 
oid cells in spleen and bone marrow after PHZ treatment probably reflects an 
increase in the number of erythroid cells, not a decrease in the absolute number 
of lymphoid cells (Table IIIB). These results strongly suggested that cells ex- 
pressing the antigen detected by antibody 18-6 were of the erythroid lineage. In 
addition, the apparent discrepancy between the frequency of 18-6 positive cells 
and o~-NBE staining in both the spleen and bone marrow (Table IIIA and B) 
further suggested that antibody 18-6 was detecting a subpopulation of erythroid 
cells presumably at a specific stage of differentiation. 
FV  Erythroleukemia  Cells and  Fetal  Liver  Express  a  Structurally  Homologous 
gp70.  The serologic cross reactivity of this "erythroid gp70" on both erythro- 
leukemia and fetal liver cells does not necessarily prove structural homology. 
Several examples exist of non-correlation between serologic cross reactivity and 
structural identity (29). In order to document that the 18-6 reactive determinant 
was expressed by a viral gp70 on the surface of these cells, we immunoprecipi- 
tated the radiolabeled cell surface proteins of early (10 d) FV spleen cells, late 
(30-60 d) FV spleen cells, the AA60 erythroleukemia cell line, and fetal liver 
cells and analyzed these proteins by SDS-PAGE. Early and late FV spleen cells 
from (B 10.A X A)F1 mice were previously found to differ in expression of both 
F-M uLV-encoded gp70 and a second gp70 unrelated to F-MuLV (13). As shown 
in Fig. 2, antibodies 18-1, 24-6, and 18-6 all precipitated a gp70-1ike polypeptide 
from the surface of late FV spleen cells, the AA60 erythroid cell line and 12-d 
fetal liver cells.  The expression of F-MuLV gp70 precipitable by antibodies 48 
and 273  and an  18-6  negative xenotropic gp70 precipitable by antibody 24-6 
indicated that early FV spleen cells were phenotypically distinct from the other 
three erythroid cell populations. Further evidence of the relatedness of the non- 
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FIGURE 2.  Live cells were surface labeled with  ~zsI, immunoprecipitated with monoclonal 
antibodies 18-1, 24-6, 18-6, and a mixture of 48+273, and the precipitates resolved by SDS- 
PAGE. Note that  18-6 precipitated a  xenotropic gp70 from fetal liver cells,  the FV-induced 
erythroid cell line AA60, and late FV-leukemic spleen cells but not from early FV spleen cells. 
Conversely, 48+273 precipitated Friend MuLV gp70 from early FV spleen cells but not from 
the other three cell populations. 
with a-chymotrypsin (CT) and resolving the fragments in two dimensions. The 
resulting  peptide  maps  of  the  gp70  from  late  leukemic  spleen  cells,  AA60 
erythroleukemia  cells,  and  fetal  liver  cells  were  strikingly  similar  and  clearly 
distinguishable from the 48 and  273 reactive gp70 of F-MuLV (Fig.  3).  These 
results indicated that  the gp70  that was expressed on fetal  liver cells,  late  FV 
erythroleukemia cells, and a cell line derived therefrom was not only antigenically 
identical but also structurally homologous. 
Discussion 
In this report,  we have demonstrated the expression of an antigenically and 
structurally  similar retroviral  gp70  on the surface  of both fetal  liver cells and 
late  FV  erythroleukemia cells.  Previously,  we  suggested that  the gp70  on  FV 
erythroleukemia  cells  was  serologically  closely  related  to  FMCF  gp70  (13). 
However, antigenic analysis with monoclonal antibodies specific for MCF viruses 
including FMCF-1  (12,  25) indicated that this gp70 did not express any MCF- 
specific  antigens,  nor  did  it  react  with  any  F-MuLV-specific  antibodies  (25) 
(Table  I).  Based  on  the  pattern  of" reactivity  with  the  panel  of  monoclonal 
antibodies used in this study, this late erythroleukemia-associated gp70 appeared 
to be xenotropic in nature and of endogenous origin. 
Monocional antibody  18-6 reacted with this gp70 both in membrane fluores- 
cence on  live cells (Table  I) and  by immunoprecipitation (Fig.  2).  It  has  been BRITT  ET  AL.  1599 
FIGURE 3.  Chymotryptic peptide maps of the  ~25I-labeled cell surface gp70  expressed  by 
early fetal liver cells, late FV-leukemic spleen cells, the erythroid cell line AA60, and Friend 
MuLV virions. No unique spots were observed among the gp70 from fetal liver, late Friend 
spleen cells, or the AA60 cell line indicating  a high degree of structural homology. The gp70 
from Friend MuLV was clearly different. Electrophoresis is in the vertical and chromatography 
in the horizontal direction. Iodinated gp70 from surface-labeled cells and F-MuLV virions was 
isolated by immunoprecipitation  and SDS-PAGE. The gp70 bands were excised from the gels, 
digested  with chymotrypsin, and the  peptide  fragments resolved in two  dimensions. Cell 
surface gp70 was immunoprecipitated with either antibody 18-1 or 18-6.  The peptide maps 
of gp70 immunoprecipitated by these two antibodies were identical (not shown), indicating 
that the predominant gp70 species in these three cell populations was  18-6+. F-MuLV gp70 
was immunoprecipitated with antibodies 48 +  273. 
reported previously that this antibody reacts with only one xenotropic and three 
to five MCF viruses (11), out of more than 50 viral isolates of diverse origin that 
have been studied. Reactivity of 18-6 with the late erythroleukemia gp70 allowed 
the  distinction  of  this  polypeptide  from  other  xenotropic  gp70's  commonly 
expressed by lymphoid cells (6).  Thus,  in  Fig.  2,  it can  be seen that early  FV 
spleen cells expressed a  gp70 that was 24-6+  but  18-6-,  indicating its antigenic 
dissimilarity to the  24-6+,  18-6+  gp70  expressed  by  late  FV  spleen and  fetal 
liver cells. It is not possible to assess the expression of an  18-6- gp70 in late FV 
spleen or fetal liver cells using this combination of monoclonal antibodies, but 
these studies are in progress. 
Several pieces of evidence suggested that the  18-6+ gp70 might be a marker 
of normal erythroid differentiation. FV erythroleukemia cell lines expressed this 
protein (Table II), whereas antibody 18-6 did not react with myeloid or lymphoid 1600  A UNIQUE ERYTHROLEUKEMIA-ASSOCIATED  RETROVIRAL gp70 
cell lines (Table II) or with thymocytes (Table III).  In addition,  this gp70  was 
present on >60%  of early fetal liver cells at the same time when 70%  of cells 
from this organ were shown to be erythroid in nature (Fig.  1, Table IIIA). The 
progressive decrease in  the frequency of 18-6  reactive cells in  maturing fetal 
liver (Fig.  1) correlated with the declining frequency of erythroid cells in  the 
fetal  liver during embryogenesis (28).  Additional evidence for the erythroid- 
associated expression of this  gp70  was the seven- to eightfold increase in  the 
frequency of  18-6  reactive  cells  in  the  spleen  and  bone  marrow  following 
treatment with  PHZ (Table IIIB).  PHZ has been shown to markedly increase 
erythropoietic activity  by  inducing  a  profound  hemolytic anemia  (24).  This 
marked  increase  in  erythropoiesis  in  the  spleen  and  bone  marrow  was  not 
accompanied by a  significant increase in myelopoiesis or lymphopoiesis (Table 
IIIB);  therefore  the  increased  frequency of  18-6  reactive  cells  was  directly 
correlated with heightened erythropoiesis. 
Several findings suggested that antibody 18-6 recognized a subpopulation of 
erythroid cells, presumably at a discrete stage of differentiation. At 12-13 d  of 
gestation, the percent of spectrin-positive and 18-6 positive cells in fetal liver was 
nearly identical, whereas at 18 days gestation the frequency of spectrin-positive 
cells was ~ 10-fold higher than 18-6 positive cells. Similarly, after treatment with 
PHZ,  >60%  of the  cells  of the  spleen  and  bone  marrow were erythroid as 
determined by histochemical staining, yet only 25% of this same cell population 
was  reactive with  antibody  18-6  (Table  IIIB).  Furthermore, in  normal adult 
animals only 3% of bone marrow cells expressed this gp70,  whereas 22%  were 
histochemically and morphologically identified as erythroid (Table IIIA).  One 
erythroid cell line (2800) was found to be negative for the  18-6+ gp70 (Table 
II)  and  may represent  a  less  mature  stage  of differentiation than  the  other 
erythroid lines studied. The erythroid nature of 2800  has been confirmed by 
enzyme histochemistry (20), the expression of erythroid spectrin (John L. Portis, 
unpublished observations), and hemoglobin induction by culture in hemin (Ste- 
ven Palmieri, unpublished observations). Further analysis of cells expressing this 
gp70  with  in  vitro  functional assays will  be  required to  define accurately the 
stage of differentiation of the hematopoietic cells expressing this protein. 
The expression of this gp70 on a  subpopulation of erythroid cells indicated 
that it should be classified as a  differentiation antigen.  Similar to other more 
well-studied retrovirus-related differentiation antigens such as Gin, Gra~,  Gerld, 
and GaksL2 (30), this protein was expressed on both normal and neoplastic cells. 
However,  in  contrast  to  the  expression  of these  differentiation antigens  on 
infectious virions recovered from normal and neoplastic lymphoid cells, we have 
been unable to recover by co-cultivation from fetal liver cells, spleen, or bone 
marrow cells of PHZ-treated mice, or late FV erythroleukemia cells, infectious 
virus expressing an  18-6+ gp70.  Furthermore, we have observed that the gp70 
detected by antibody 18-6 was expressed on fetal liver cells of a variety of mouse 
strains, including AKR/J, C57BL/10Sn, C57BL/6J, BALB/c, A/WySn, DBA/2, 
and NFS,  whereas the lymphoid differentiation antigens, G~x, Grada, Gerla, and 
GaksL2 exhibit extensive genetically restricted expression (30). 
Although  products  of endogenous  retroviruses  can  be  detected  in  tissues 
actively undergoing differentiation (7), their function in the process of differen- BRITT ET AL.  1601 
tiation has never been established (31). A chicken strain has been produced that 
lacks  endogenous viral  sequences,  suggesting that  they  have  no  role  in  the 
differentiation of avian hematopoietic cells (32).  Our inability to find a  mouse 
strain that lacks the "erythroid gp70" perhaps suggests a selective advantage for 
this protein in evolution. It has been suggested that endogenous gp70's may, in 
fact, protect cells from infection by pathogenic retroviruses through a mechanism 
of interference (33).  Conversely, the sequences encoding such proteins may be 
under the same transcriptional control as functionally relevant, perhaps neigh- 
boring, sequences activated during the respective stage of differentiation (31). 
Regardless of its function, the expression of the  18-6  reactive gp70 on FV 
erythroleukemia cells from the late phase of Friend disease should allow a more 
accurate investigation into the stage of differentiation of the erythroid progenitor 
cells that are transformed by the FV complex. Previous reports have suggested 
that FV-induced leukemia is a multistage disease with an early, hyperproliferative 
nonmalignant phase and a late malignant phase (34, 35). This would suggest that 
two different cellular phenotypes are present during the disease. Our preliminary 
results support this hypothesis. Late in the course of disease, a major population 
of spleen cells expressed the 18-6+ gp70 (Table I), whereas early in the disease 
these cells were found only in low frequency (data not shown). In addition, we 
could detect an  18-6+  gp70 by immunoprecipitation in late but not early FV 
spleen cells (Fig. 2). Whether this gp70 has a role in the malignant transition or 
is  merely a  useful phenotypic marker  for  malignant erythroleukemia cells  is 
currently being investigated. 
Summary 
Late in the course of Friend virus (FV)-induced erythroleukemia, leukemic 
spleen cells express a cell surface retroviral gp70 envelope protein not detected 
during the early proliferative phase of the disease. Characterization of this gp70 
revealed it was unrelated to the input Friend murine leukemia virus (F-MuLV), 
but antigenically similar to a  unique subset of endogenous xenotropic viruses. 
This gp70 was expressed by murine erythroleukemia cell lines but has not been 
identified on cell lines of  other lineages. A monoclonal antibody (l 8-6) specifically 
reactive  with  this polypeptide was  used to  examine hematopoietic organs of 
normal  uninoculated  mice.  This  antibody  detected  a  gp70  expressed  by  a 
majority of erythroid cells in fetal liver and by a small but significant percentage 
of normal adult spleen and bone marrow cells. Increased erythropoietic activity 
induced by treatment of adult mice with phenylhydrazine (PHZ) resulted in a 
seven- to eightfold increase in the frequency of spleen and bone marrow cells 
expressing this gp70. Peptide map analysis indicated that the 18-6 reactive gp70 
expressed by Friend erythroleukemia cells and by cells from normal fetal liver 
were structurally identical. These results suggested that this unique gp70 was an 
erythroid-specific differentiation antigen. 
The authors wish to thank Helen Blahnik for editing and typing this manuscript. 
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